Chul‐Hak Yang

1.5k total citations
35 papers, 1.4k citations indexed

About

Chul‐Hak Yang is a scholar working on Molecular Biology, Plant Science and Neurology. According to data from OpenAlex, Chul‐Hak Yang has authored 35 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 6 papers in Plant Science and 4 papers in Neurology. Recurrent topics in Chul‐Hak Yang's work include RNA Interference and Gene Delivery (4 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and DNA and Nucleic Acid Chemistry (4 papers). Chul‐Hak Yang is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and DNA and Nucleic Acid Chemistry (4 papers). Chul‐Hak Yang collaborates with scholars based in South Korea, United States and Ethiopia. Chul‐Hak Yang's co-authors include Seung R. Paik, Jongsun Kim, Seyeon Park, Eun‐Ryeong Hahm, Hyun-Won Kim, Yonghoon Choi, Sangkyou Lee, Ju Hyung Lee, Haeyoung Kwon and Jeon Han Park and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Biochemistry.

In The Last Decade

Chul‐Hak Yang

34 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chul‐Hak Yang South Korea 20 732 290 212 150 120 35 1.4k
Fengtian Xue United States 27 738 1.0× 163 0.6× 312 1.5× 104 0.7× 95 0.8× 90 1.9k
R. Rajasekaran India 19 763 1.0× 219 0.8× 187 0.9× 91 0.6× 120 1.0× 112 1.4k
Steven H. Olson United States 24 669 0.9× 246 0.8× 252 1.2× 133 0.9× 221 1.8× 47 1.7k
Fernando L. Palhano Brazil 21 669 0.9× 161 0.6× 441 2.1× 123 0.8× 93 0.8× 44 1.4k
Nianyu Li United States 8 845 1.2× 138 0.5× 145 0.7× 138 0.9× 72 0.6× 10 1.4k
Simona D’Aguanno Italy 25 1.1k 1.5× 103 0.4× 249 1.2× 127 0.8× 70 0.6× 45 1.7k
Arun Upadhyay India 23 971 1.3× 53 0.2× 192 0.9× 115 0.8× 140 1.2× 50 1.9k
Clara Iannuzzi Italy 25 969 1.3× 156 0.5× 470 2.2× 249 1.7× 43 0.4× 50 1.8k
Lars Hesse Germany 17 941 1.3× 69 0.2× 1.2k 5.5× 163 1.1× 275 2.3× 21 2.1k

Countries citing papers authored by Chul‐Hak Yang

Since Specialization
Citations

This map shows the geographic impact of Chul‐Hak Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chul‐Hak Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chul‐Hak Yang more than expected).

Fields of papers citing papers by Chul‐Hak Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chul‐Hak Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chul‐Hak Yang. The network helps show where Chul‐Hak Yang may publish in the future.

Co-authorship network of co-authors of Chul‐Hak Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Chul‐Hak Yang. A scholar is included among the top collaborators of Chul‐Hak Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chul‐Hak Yang. Chul‐Hak Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hahm, Eun‐Ryeong, Ju Hyung Lee, Chi Hoon Park, et al.. (2005). Momordin I, an inhibitor of AP-1, suppressed osteoclastogenesis through inhibition of NF-κB and AP-1 and also reduced osteoclast activity and survival. Biochemical and Biophysical Research Communications. 337(3). 815–823. 20 indexed citations
3.
Park, Chi Hoon, Ju Hyung Lee, & Chul‐Hak Yang. (2005). Curcumin Derivatives Inhibit the Formation of Jun-Fos-DNA Complex Independently of their Conserved Cysteine Residues. BMB Reports. 38(4). 474–480. 24 indexed citations
4.
Hahm, Eun‐Ryeong, et al.. (2004). Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis. Biochemical and Biophysical Research Communications. 321(2). 337–344. 88 indexed citations
5.
Park, Seyeon, et al.. (2004). Determination of binding constant of transcription factor myc–max/max–max and E-box DNA: the effect of inhibitors on the binding. Biochimica et Biophysica Acta (BBA) - General Subjects. 1670(3). 217–228. 29 indexed citations
6.
Choi, Eun‐Jin, et al.. (2004). α-Synuclein has structural and functional similarities to small heat shock proteins. Biochemical and Biophysical Research Communications. 324(4). 1352–1359. 32 indexed citations
8.
Park, Sang Myun, et al.. (2002). Distinct Roles of the N-terminal-binding Domain and the C-terminal-solubilizing Domain of α-Synuclein, a Molecular Chaperone. Journal of Biological Chemistry. 277(32). 28512–28520. 96 indexed citations
9.
Hahm, Eun‐Ryeong, et al.. (2002). New and known symmetrical curcumin derivatives inhibit the formation of Fos-Jun-DNA complex. Cancer Letters. 184(1). 89–96. 57 indexed citations
10.
Kwon, Haeyoung, et al.. (2001). Inhibitory Effect of Paeoniflorin on Fos-Jun-DNA Complex Formation and Stimulation of Apoptosis in HL-60 Cells. BMB Reports. 34(1). 28–32. 6 indexed citations
11.
Jun, Gyo, et al.. (2001). Inhibitory Effect of Methyl Caffeate on Fos-Jun-DNA Complex Formation and Suppression of Cancer Cell Growth. Bulletin of the Korean Chemical Society. 22(10). 1131–1135. 12 indexed citations
12.
Kwon, Haeyoung, et al.. (2001). Determination of binding constant of transcription factor AP‐1 and DNA. European Journal of Biochemistry. 268(3). 565–572. 32 indexed citations
13.
Cho, Seongeun, et al.. (2001). Analysis of FcγRIII and IgG Fc Polymorphism Reveals Functional and Evolutionary Implications of Protein–Protein Interaction. Journal of Molecular Evolution. 53(1). 1–9. 7 indexed citations
14.
Paik, Seung R., et al.. (2000). Structural changes in α‐synuclein affect its chaperone‐like activity in vitro. Protein Science. 9(12). 2489–2496. 109 indexed citations
15.
Choi, Yonghoon, Chul‐Hak Yang, Hyun-Won Kim, & Seunho Jung. (2000). Monte Carlo simulations of the chiral recognition of fenoprofen enantiomers by cyclomaltoheptaose (β-cyclodextrin). Carbohydrate Research. 328(3). 393–397. 18 indexed citations
16.
Park, Seyeon, et al.. (1999). Suppression of AP-1 Activity by Tanshinone and Cancer Cell Growth Inhibition. Bulletin of the Korean Chemical Society. 20(8). 925–928. 19 indexed citations
17.
Lee, Sang‐Kyou, et al.. (1999). Quantitative Assay for the Binding of Jun-Fos Dimer and Activator Protein-1 Site. BMB Reports. 32(6). 594–598. 1 indexed citations
18.
Choi, Yonghoon, Sebyung Kang, Chul‐Hak Yang, Hyun-Won Kim, & Seunho Jung. (1999). On the Unusual Homeoviscous Adaptation of the Membrane Fatty Acyl Components against the Thermal Stress in Rhizobium meliloti. Bulletin of the Korean Chemical Society. 20(6). 753–756. 5 indexed citations
19.
Kim, Hyun-Kyung & Chul‐Hak Yang. (1999). Active site determination of yeast geranylgeranyl protein transferase type I expressed inEscherichia coli. European Journal of Biochemistry. 265(1). 105–111. 1 indexed citations
20.
Lee, Sangkyou, Seyeon Park, Jae‐Wook Oh, & Chul‐Hak Yang. (1998). Natural Inhibitors for Protein Prenyltransferase. Planta Medica. 64(4). 303–308. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026